Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PKI - Enzo Biochem names new CEO replacing Elazar Rabbani

PKI - Enzo Biochem names new CEO replacing Elazar Rabbani

PerkinElmer Inc.
Enzo Biochem (NYSE:ENZ) has added ~6.1% in the pre-market after the company announced Hamid Erfanian as its new CEO effective Nov. 08. Mr. Erfanian will replace former CEO Elazar Rabbani, who will step down according to a previously announced succession plan. Dr. Rabbani will become the chief scientific officer and retain the position as the chairperson of the Board of Directors, Enzo (ENZ) said. A 28-year veteran in healthcare, Mr. Erfanian most recently served as the chief commercial officer of EUROIMMUN, a unit of PerkinElmer (NYSE:PKI). Prior to that, he was the CEO of the company’s U.S. subsidiary from June 2014 through August 2021. Enzo (ENZ) announced the leadership transition in March after top investor Harbert Discovery Fund urged the immediate resignation of the CEO Dr. Rabbani.

For further details see:

Enzo Biochem names new CEO replacing Elazar Rabbani
Stock Information
Company Name: PerkinElmer Inc.
Stock Symbol: PKI
Market: NYSE
Website: perkinelmer.com
Menu
PKI PKI Quote PKI Short PKI News PKI Articles PKI Message Board
Get PKI Alerts

News, Short Squeeze, Breakout and More Instantly...